Greg
@GregNowakowski
oncology hematology lymphoma ASCO ASH
Lots of great connections happening at #ASCO24 (mainly thanks to this pin). Stop by and say 👋 to Dr. @GregNowakowski and our experts at @MayoClinic booth no. 27104!
Right in time! Nice paper of 🇮🇹🇨🇿🇨🇭🇺🇸centers out! Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG) @StefanoLuminari @GregNowakowski @MarekTrnenyDr onlinelibrary.wiley.com/doi/epdf/10.10…
CONGRESS | #18ICML | PRESENTATION Patrick B Johnston, @MayoClinic highlights results from the phase II DAILY II US trial of zamtocabtagene autoleucel in patients with R/R CNSL (N = 16). Zamto-cel was well tolerated in patients with R/R CNSL, with encouraging efficacy (ORR,…
Pola-R-CHP the new SOC for ALL DLBCL? @SoniSmithMD YES vs. @GregNowakowski NO Pola-R-CHP, RCHOP Some need Pola-R-CHP Some don't have access to Pola Some will be fine with RCHOP @icmlugano #18ICML #lymsm
Dr Ansell discussing plenary abstract ICML Lugano on predicting response to CART by microenvironment signature @MayoCancerCare
Late-breaking abstract featured at #ASCO25: @MayoClinic researchers found the addition of #immunotherapy to chemotherapy can reduce the recurrence and spread of #ColonCancer in patients with deficient DNA mismatch repair (dMMR). Learn more: newsnetwork.mayoclinic.org/discussion/imm… @FASinicropeMD
Thank you @MayoClinic for recognizing Dr. Lee Greenberger, our SVP & Chief Scientific Officer of 11 years, for his service in the #BloodCancer space and collaboration in IMPACT grants last night. #ASH24 🔬🩸
Honored to be on the ballot for the Designated Community Oncology seat. ASCO has done a remarkable job of selecting a lineup of brilliant candidates. I personally have SO MUCH respect for each one of them! Your voice counts, please vote. asco.org/election @ASCO @ASCOPres
We are seeking a lymphoma investigator to join our Lymphoid Malignancies Disease Group at @MayoClinic in Rochester, MN. Join @GregNowakowski, Steve Ansell, @WitzigLab and may other talented individuals to advance lymphoma care and research. jobs.mayoclinic.org/job/rochester/…
I’m honored to be on the ballot for the ASCO Board of Directors with all the other amazing candidates. Learn more and 🗳️ ⬇️
Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
Great discussion on the present and future of oncology drug development with Dr. Rick Pazdur - Distinguished Lecturer at MCCCC. @realrickpazdur @MayoCancerCare @US_FDA
Dinner with @GregNowakowski and my excellent junior colleagues after great Gregg’ s talk and discussion in @UniKarlova Gen Hospital
100 years of Hematology @MayoClinic Rochester, MN Hematology Division Faculty @MayoCancerCare
Grzegorz S. Nowakowski, MD, discusses the accelerated approval of epcoritamab in follicular lymphoma, touching on key trial data and remaining unmet needs. @GregNowakowski @MayoClinic #lymsm #oncology #MedTwitter onclive.com/view/epcoritam…
PhD thesis today @ComeBommier discussing about MZL, surrogacy, endpoints. Strong collaboration with Mayo Clinic, Congratulations !
An ASCO task force paper published today in @JournalCancer details 3 calls-to-action for the oncology research and care communities that could expand access to clinical trials and enable patients to participate closer to home. Learn more: brnw.ch/21wFVie #OncTwitter
Great to join @FDAOncology, @AACR, @AmstatNews for today's workshop on Overall Survival in cancer clinical trials Nice introduction from @FDAOncology's Dr Gormley on different endpoint considerations & nuances of interpreting OS #AACRSciencePolicy @tmprowell
Join us for the ASH|FDA Collaboration: A Workshop on Regulatory Science in Hematology to gain a deeper understanding of the @US_FDA’s role in #hematology 🩸 Learn about product development, clinical trial design, & more! Apply now: loom.ly/lvtrMmQ
Looking forward joining discussion with great faculty colleagues at the PER symposium on experts addressing burning questions in DLBCL at ASCO in Chicago on June 2! Sign up today! bit.ly/3MMyTqS #HemOnc #gotoPER